Web: http://www.mnmconferences.com/cancer-diagnosis-therapy-congress.html Theme: Advancement in Cancer diagnosis and Challenges in Organ Specific Cancer Treatment
Event Overview MarketsnMarkets Conferences (MnM Conferences) is delighted to announce the inaugural Cancer Diagnosis & Therapy Congress to be held on September 3-4, 2015 London, UK. The two day program will address key concerns such as cancer Immunotherapy, molecular targeted therapy, metabolomics in cancer tumour assessments & profiling, nanotechnology in cancer therapy, hormone therapy, stem cell Transplantation, surgical oncology, epigenetics, cancer genomics, cancer biomarkers, bio banking, noninvasive cancer diagnostics, organ specific cancers, cancer epidemiology and clinical trial in cancer research. Bringing together 150 + experts from industry, research laboratories, hospitals, device and diagnostic manufacturers and academia in the arena of cancer research, the Cancer Therapy and Diagnosis Congress will provide an international platform to meet and network with experts from around the globe through scientific and industry oriented sessions, panel discussions, symposiums, workshops and vibrant exhibition area. Major segments to be discussed: • Advanced Cancer Detection, Diagnosis Methods and Technologies • Novel Approaches to Cancer Therapy • Emerging Challenges in Organ Specific Cancers Research
Why Attend? • 25+ experts in the arena of Cancer research both from industry and academia • 20+ focused discussions on challenges and opportunities • 400+ minutes of networking • One- on- One interactions with key experts in the industry • Post event follow up providing all documentation from the meeting • Tailor-made agenda • World class exhibitions, symposiums, workshops
Attendee Profile The conference aim is to gather broad range of professionals involved in cancer research including: • Healthcare professionals • Scientists working in cancer, Cancer clinicians and clinical scientists • Academic researchers, students • Medical oncologists, Hematologists, pathologists, immunologists, radiation oncologists, surgeons • Other organ system specialists treating cancer patients • Pharma and biotech professionals developing novel cancer therapies and diagnostics • Representatives of pharmaceutical companies • Device manufacturers & service providers • Patient support teams, advocacy groups, cancer networks and survivors • Professionals and volunteers engaged in palliative care • Professionals, engaged in monitoring, fundraising • Decision Makers from Government & NGOs
Confirmed Speakers Prof. Peixuan Guo William Farish Endowed Chair in Nanobiotechnology, Director of Nanobiotechnology Center University of Kentucky, USA Prof. Hani Gabra Director, Ovarian Cancer Action Research Centre, Imperial College Healthcare NHS Trust, London UK
Prof. Riccardo A. Audisio University of Liverpool President,European Society of Surgical Oncologists &BASO UK Prof. Stefan Gluck Vice President Global Medical Affairs, Celgene USA
Prof. Christopher Twelves Deputy Director of Cancer Research UK, Clinical Centre, St James’s Hospital, Leeds UK
Prof. Thomas J. Vogl Director, Department of Diagnostic and Interventional Radiology Wolfgang Goethe-University Germany
Prof. KarimNayernia Co-Director & Head of Department of Stem Cell Medicine Newcastle University UK Prof. Lesley Fallowfield Director:(SHORE-C) Brighton & Sussex Medical School University of Sussex UK Prof. Michael Lisanti Director of the Breakthrough Breast Cancer Research Unit, Cancer Research UK Manchester Institute UK
Dr. John Castle Senior Director Bioinformatics Agenus& 4-Antibody AG, Basel Switzerland
Prof. Peter J. Parker London Research Institute CRUK Lincoln's Inn Fields King's College London UK
Prof. Michelle Garrett University of Kent General Secretary, The British Association for Cancer Research UK
Prof. Edward Leen Chair of Radiology Imperial College London Hammersmith Hospital Campus UK Prof. Robert Hawkins Director of Medical Oncology University of Manchester and Christie Hospital, Cancer Research UK UK Brett Wilson CEO/ Founder Walking Miracles Inc USA
Prof. Kristijan Ramadan Associate Professor and MRC Senior Group Leader, CRUK/MRC Oxford Institute for Radiation Oncology UK Dr. Gianni Mura Surgical Oncologist and General Surgeon Valdarno Hospital, Arezzo Italy William P. Chastain Director APeX Disease Reserch Institute USA
Dr. Raul Cordoba Fundacion Jimenez Diaz University Hospital, Madrid Spain
Prof. Pedro RondotRadío, MD University of Buenos Aires Army Social Security Argentina
Prof. Robert Brown Head of Division of Cancer / Chair in Translational Oncology Imperial College London UK Prof. Ken Mills Chair, Experimental Haematology Centre for Cancer Research and Cell Biology, Queen’s University Belfast, UK
Prof. Kathryn Ball Chair in Biochemistry and Cell Signalling Edinburgh Cancer Research Centre UK Prof. Marek K. Janiak Head, Dept. of Radiobiology and Radiation Protection, Military Institute of Hygiene and Epidemiology Poland Hassan Z Malik University Hospital Aintree Honorary Secretary, British Association of Surgical Oncology UK
Dr. Dana Flavin-Konig Executive Director Foundation for Collaborative Medicine and Research USA Dr. Esther Baena Group Leader, Cancer Research UK Manchester InstituteThe University of Manchester UK Dr. Alan Prem Kumar Cancer Science Institute of Singapore, School of Biomedical Sciences, Curtin University Australia
Dr. Michela Garofalo Group Leader, Transcriptional Networks in Lung Cancer CRUK, The University of Manchester UK
Dr. Christos Christopoulos Consultant, Radiation Oncologist Metropolitan Hospital Greece
Dr. Claus Jorgensen Group Leader, Systems Oncology Cancer Research UK Manchester Institute, The University of Manchester UK Prof. Arnie Purushotham Director of King's Health Partners Integrated Cancer Centre, ViceDean International, King’s College London UK Dr. Francois Lassailly Head, In Vivo Imaging London Research Institute Cancer Research UK UK
Dr. Ilaria Malanchi Group Leader, Tumour Host Interaction Lab, Cancer Research UK London Research Institute UK
Prof. Jacqui Shaw Professor of Translational Cancer Genetics, Department of Cancer Studies, University of Leicester UK
Dr. Fernando Calvo Team Leader, Division of Cancer Biology, The Institute of Cancer Research UK
Dr. James M Flanagan Non-Clinical Senior Lecturer Department of Surgery & Cancer Imperial College London UK Prof. Jude Fitzgibbon Professor of Personalised Cancer Medicine, Barts Cancer Institute Queen Mary University of London UK
Prof. Feng-Chi Ho President, Global Oncology Academy, Visiting Proffessor Guangzhou East Cancer Hospital China Dr. Alan G. Ramsay[Reserved] Team Leader, Lymphoma Immunology, Department of HematoOncology, King's College London UK
Prof. Pedro Estrela Associate Professor Department of Electronic & Electrical Engineering, University of Bath UK Dr. John Brognard Group Leader, Signalling Networks in Cancer, CRUK, The University of Manchester UK
Conference Synopsis
Stream-1 (Cancer Diagnosis) Advanced Cancer Diagnosis Methods and Technologies • • • • • • • • • •
Next-gen sequencing for diagnosis and monitoring of cancers Biomarkers in cancer diagnosis and prognosis Clinical proteomics & metabolomics assays for cancer biomarkers discovery Role of Biobank establishment for cancer research & treatment Image-guided photodynamic therapy of oral leukoplakia Advancements in CT Scan, MRI Scan, Mammograms, Radiography etc. High resolution microendoscopy , CryoPen, cryotherapy device Non-invasive cancer diagnostics: MR guided Focused Ultrasound Surgery Camera pill technology & 3D printing technology in cancer detection Portable computer-aided detection and diagnostic (CADD) tools
Emerging Challenges in Organ Specific Cancers Research • Breast, Prostate, Lung, Pancreatic, ovary and other organ specific cancers • Cancer Epigenetics, MicroRNAs and Long Noncoding RNAs • Novel medical practices in clinical oncology • Clinical trials, regulatory affairs and ethical challenges • Challenges in healthcare IT : Cancer Databases, Bioinformatics in cancer research, clinical and scientific data management • Cancer Epidemiology, control and palliative care • pathogens as origins or accompaniment in cancers
Stream-2 (Cancer Therapy) Novel Approaches to Cancer Therapy • Cancer Immunotherapy • Molecular Targeted Cancer Therapy and precision medicines • Metabolomics approach towards cancer therapy • Nanotechnology in cancer therapy • Genomic tumor assessment & tumor molecular profiling • Hormone therapies & Gene expression modulators • Small Oligonucleotides therapy • New Therapies with pleiotropic activity (including HDAC, Bromodomain modulators, HSP90, IMIDs, Proteasome) • Hematopoietic Cell, Bone marrow, stem cell transplantation to treat cancer • Stem Cell Transplantation for Cancer treatment Hematopoietic Cell, Bone marrow and stem cell transplantation Cancer Stem Cell Markers Mass stem cells production technologies
Contact Us Asia:
United Kingdom:
UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar Pune, MH 411013 India Tel. +91 20 6075 6011
The Kidlington Centre Kidlington, Oxfordshire OX5 2DL United Kingdom Tel. +44 (0)1865-842-976
For Speaker, Delegate& Poster opportunity/ Suggestions: Rajesh Guru Email:
[email protected] Mob: +91-8796 554 246 / Tel: +91 20 67256006 For worldwide media partner/ collaboration: Namrata Naikpawar Email:
[email protected] Mob: +91-8796 554 246 / Tel: +91 20 60756011 For Sponsorship/ Exhibition: Steve Hambrook Email:
[email protected]
http://www.mnmconferences.com/cancer-diagnosis-therapy-congress.html
[email protected] India: +91 20 6075 6011 (O)/ +91-8796 554 246 (M) UK: +44 1865 842 976
